Gary L Pattee

6PUBLICATIONS
10CO-AUTHORS
Environmental epidemiologyGlycoconjugatesElectrical energy transmission, networks and systemsBioavailability and ecotoxicologyClinimetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 09, 2025
Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment.

Angela Genge, Gary L Pattee, Gen Sobue

|Dec 20, 2024
Carbohydrate-mediated interactions between chloroviruses and the immune system.

Immacolata Speciale, Anna Notaro, Sven Bruijns

|Nov 08, 2024
Gastrostomy in Amyotrophic Lateral Sclerosis: Timing Enhances Survival.

Gary L Pattee

|Dec 12, 2022
Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment.

Angela Genge, Gary L Pattee, Gen Sobue

|Oct 11, 2022
A clinical bulbar assessment scale (CBAS) for amyotrophic lateral sclerosis.

Laura J Ball, Jenenne A Geske, Elizabeth Burton

|Jun 16, 2021
Neuromuscular disease pearl: Don't overlook the swallow.

Gary L Pattee

Pageof 1

Frequent Collaborators

2 joint publications

Stephen Apple

1 joint publications

Laura J Ball

1 joint publications

Jenenne A Geske

1 joint publications

Immacolata Speciale